GSK-8999
CAS No. 1422355-59-6
GSK-8999 ( GSK-2578999 )
Catalog No. M11773 CAS No. 1422355-59-6
GSK-8999 (GSK-2578999) is a novel, potent HIV-1 maturation inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 1683 | Get Quote |
|
50MG | 3402 | Get Quote |
|
100MG | 4680 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK-8999
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK-8999 (GSK-2578999) is a novel, potent HIV-1 maturation inhibitor.
-
DescriptionGSK-8999 (GSK-2578999) is a novel, potent HIV-1 maturation inhibitor with IC50 values of 17 nM, 23 nM, 25 nM, and 8 nM for wild type, Q369H, V370A, and T371A respectively; shows high potency against 57 of 62 isolates demonstrating an improvement over the first generation maturation inhibitor BVM; has a mechanism of action consistent with inhibition of the proteolytic cleavage of CA-SP1.
-
SynonymsGSK-2578999
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number1422355-59-6
-
Formula Weight776.44
-
Molecular FormulaC46H62ClNO7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)C(C)(C)CC(O[C@@H](CC[C@]1(C)[C@@]2([H])CC[C@@]34[H])C(C)(C)[C@]1([H])CC[C@@]2(C)[C@]3(C)CC[C@]5(C(C(NC6(C7=CC=C(Cl)C=C7)CC6)=O)=O)C4=C(C(C)C)C(C5)=O)=O
-
Chemical Name(3β)-3-(3-Carboxy-3-methyl-1-oxobutoxy)-N-[1-(4-chlorophenyl)cyclopropyl]-α,21-dioxo-28-norlup-18-ene-17-acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tang J, et al. Bioorg Med Chem Lett. 2017 Jun 15;27(12):2689-2694.
molnova catalog
related products
-
Saquinavir mesylate
Apotent and selective inhibitor of HIV-1 protease with IC50 of 0.5-6 nM in cell assays.
-
HIV-1 integrase inhi...
HIV-1 integrase inhibitor is an HIV-1 integrase inhibitor.
-
BMS-818251
BMS-818251 (BMS818251) is a novel potent, small-molecule inhibitor of HIV-1 entry with EC50 of 0.019 nM against e laboratory-adapted HIV-1 strain NL4-3.